Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

被引：0
|
作者：
Simone Gerzeli
Carla Rognoni
Silvana Quaglini
Maria Caterina Cavallo
Giovanni Cremonesi
Alberto Papi
机构：
[1] University of Pavia,Department of Political and Social Sciences
[2] University of Pavia,Laboratory for Biomedical Informatics, Department of Computer Engineering and Systems Science
[3] Bocconi University,Centre for Research on Health and Social Care Management (CERGAS)
[4] Chiesi Farmaceutici S.p.A.,Research Centre on Asthma and COPD
[5] University of Ferrara,undefined
来源：
Clinical Drug Investigation | 2012年 / 32卷
关键词：
Asthma; National Health Service; Probabilistic Sensitivity Analysis; Asthma Management; Successful Control;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Asthma is a chronic disease characterized by acute symptomatic episodes with variable severity and duration. Pharmacological asthma management aims to achieve and maintain control without side effects, thus improving quality of life and reducing the economic impact. Recently, a clinical trial showed the non-inferiority of beclomethasone/formoterol (BDP/F) versus fluticasone propionate/salmeterol (FP/S) in adults with moderate to severe persistent asthma. However, this study did not provide evidence on costs and did not quantify quality-of-life parameters.
引用
收藏
页码：253 / 265
页数：12
相关论文
共 50 条
  • [31] Cost-effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain
    Lindgren, B
    Sears, MR
    Campbell, M
    Villasante, C
    Huang, S
    Lindh, A
    Petermann, W
    Svensson, K
    Berggren, F
    Pauwels, RA
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (01) : 62 - 68
  • [32] Cost-utility of a disease management program for patients with asthma
    Steuten, Lotte
    Palmer, Stephen
    Vrijhoef, Bert
    van Merode, Frits
    Spreeuwenberg, Cor
    Severens, Hans
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (02) : 184 - 191
  • [33] Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma
    Corren, Jonathan
    Mansfield, Lyndon E.
    Pertseva, Tetyana
    Blahzko, Viktor
    Kaiser, Kirsten
    RESPIRATORY MEDICINE, 2013, 107 (02) : 180 - 195
  • [34] Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 μg twice daily and budesonide 800 μg twice daily in the treatment of adults and adolescents with asthma
    Lundbäck, B
    Jenkins, C
    Price, MJ
    Thwaites, RMA
    RESPIRATORY MEDICINE, 2000, 94 (07) : 724 - 732
  • [35] Cost Utility of Bronchial Thermoplasty for Severe Asthma: Implications for Future Cost-Effectiveness Analyses Based on Phenotypic Heterogeneity
    Keim-Malpass, Jessica
    Malpass, H. Charles
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 427 - 437
  • [36] Real-life cost-effectiveness of benralizumab in patients with severe asthma
    A. Padilla-Galo
    A. J. García-Ruiz
    R. Ch. Levy Abitbol
    C. Olveira
    F. Rivas-Ruiz
    N. García-Agua Soler
    M. Pérez Morales
    B. Valencia Azcona
    B. Tortajada-Goitia
    I. Moya-Carmona
    A. Levy-Naon
    Respiratory Research, 22
  • [37] Cost-effectiveness of benralizumab in patients with uncontrolled severe eosinophilic asthma in Spain
    Mareque, M.
    Climente, M.
    Martinez-Moragon, E.
    Padilla, A.
    Oyaguez, I.
    Touron, C.
    Torres, C.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [38] Real-life cost-effectiveness of benralizumab in patients with severe asthma
    Padilla-Galo, A.
    Garcia-Ruiz, A. J.
    Levy Abitbol, R. Ch.
    Olveira, C.
    Rivas-Ruiz, F.
    Garcia-Agua Soler, N.
    Perez Morales, M.
    Valencia Azcona, B.
    Tortajada-Goitia, B.
    Moya-Carmona, I.
    Levy-Naon, A.
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [39] Cost-effectiveness of mepolizumab for severe eosinophilic asthma in China
    Xiong, Chaogang
    An, Mengna
    Zhen, Wang
    Ying, Li
    Xin, Gu
    Xin, Zhang
    Zhang, Shengjie
    Yuan, Zhao
    Qian, Lei
    Ma, Wenbin
    Feng, Weiyi
    JOURNAL OF ASTHMA, 2024, 61 (09) : 1068 - 1075
  • [40] Cost-effectiveness of including salmeterol in asthma therapy in a primary care setting in Japan
    Miyagawa, T
    Arakawa, I
    Shiragami, M
    Nishimura, S
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 (01): : 51 - 59
12345